Trilantic, the private equity firm focused on mid-market transactions, completed the investment in Smile Eyes Group, a player in the German ophthalmology market headquartered in Munich. Financial terms were not disclosed. "We are impressed by Smile Eyes’s attractive position in the German ophthalmology market. Dres. Wiltfang and Bechmann have built an impressive network of highly specialised ophthalmic experts and we are excited to partner with them and their team to support their expansion strategy centred around the Smile Eyes concept," Henrik Bodenstab, Trilantic Partner.